Meetings and Events

Game, set and match for Spirit Group!

Our Spirit Group summer business update provided a fantastic opportunity to bring together the majority of the Spirit Group family – our Didsbury and Alderley Park teams and our remote workers from across the UK. We celebrated a further quarter of medical communications success and growth, and our enthusiastic and forward-thinking Working Groups updated us…Read more »

Our Spirit Group summer business update provided a fantastic opportunity to bring together the majority of the Spirit Group family – our Didsbury and Alderley Park teams and our remote workers from across the UK. We celebrated a further quarter of medical communications success and growth, and our enthusiastic and forward-thinking Working Groups updated us on the business initiatives they have been prioritising to further enhance the executional and operational excellence that Spirit Group is renowned for.

The day was rounded off nicely with our own Wimbledon-themed event – complete with Pimms, strawberries & cream and lots of Spirited fun!

Share

TwitterFacebookLinkedInGoogle+Email

Spirit Group at EULAR 2018

This year’s European League Against Rheumatism (EULAR) congress was a busy one indeed! A record breaking >5000 abstract submissions and 32 industry-supported symposia, many running simultaneously, reflecting the highly-competitive nature of the meeting and underscoring the need for communications and content with a difference. Key front page EULAR Congress News themes included: Patient engagement with…Read more »

This year’s European League Against Rheumatism (EULAR) congress was a busy one indeed! A record breaking >5000 abstract submissions and 32 industry-supported symposia, many running simultaneously, reflecting the highly-competitive nature of the meeting and underscoring the need for communications and content with a difference.

Key front page EULAR Congress News themes included:

Patient engagement with their treatment and their disease
Enabling and encouraging patients to be more than passive participants in their own care was a very hot topic. Dr Yeliz Prior, PhD, Director of postgraduate research at the School of Health Sciences at the University of Salford in Manchester, UK noted that “We know that patient information and education have been shown to improve pain, self-efficacy and overall quality of life in people with musculoskeletal conditions (MSCs)”.  She added that “Informed patients are better equipped to distinguish and manage the symptoms of MSCs, use treatments effectively, identify and access [the] appropriate health and social care services they need, manage work and develop better coping strategies to deal with the negative psychological impact of their own conditions, such as stress, anxiety and depression”.

The ‘Don’t Delay, Connect Today’ campaign
The theme of patient engagement was also reflected in EULARs ‘Don’t Delay, Connect Today’ campaign. The campaign is now in its second year and aims to raise awareness of how important early diagnosis, and early treatment where indicated, is in preventing further damage for people with rheumatic and musculoskeletal diseases (RMDs). Prof. Gerd R. Burmester (Past President of EULAR and Professor of medicine at Berlin’s Charité University Clinic) noted that by encouraging people to work together, positive steps can be taken to improve the lives of those living with RMDs. This is particularly significant as awareness of the importance of early diagnosis is limited amongst the general public, in people with RMDs, and even among many doctors and health professionals in rheumatology.

Biosimilar use
The importance of keeping the patient at the centre of the decision to switch from an originator biologic to a biosimilar was also at the forefront of many presentations and discussions. There was a call for more randomised controlled trials on the safety of multiple switching, and discussion about the vital role of pharmacovigilance in confirming the safety of all biologics on a long-term basis.

We’re looking forward to next year’s agenda already!

Share

TwitterFacebookLinkedInGoogle+Email

Spirit Group at the 23rd congress of the European Hematology Association

This weekend Spirit Group were in Stockholm, attending the 23rd congress of the European Hematology Association, one of the largest hematology events of the year. Hot topics this year included: The increasing use of biomarkers in the treatment of hematological malignancies. In addition to their prognostic value, biomarkers are increasingly being used to guide treatment…Read more »

This weekend Spirit Group were in Stockholm, attending the 23rd congress of the European Hematology Association, one of the largest hematology events of the year.

Hot topics this year included:

  • The increasing use of biomarkers in the treatment of hematological malignancies. In addition to their prognostic value, biomarkers are increasingly being used to guide treatment by identifying patients likely to respond to particular therapies or those at increased risk of adverse events.
  • The move away from chemotherapies towards using combinations of targeted therapies to treat indolent Non-Hodgkin lymphoma. With a plethora of targeted therapies either approved or under investigation for use in these indications, including anti-CD20 monoclonal antibodies and B-cell receptor signaling inhibitors, the key challenge will be finding out the optimal way to combine these powerful agents.

This years’ presidential symposium (a session covering abstracts of particularly important scientific interest) included data from two studies involving rituximab, an anti-CD20 monoclonal antibody, in non-Hodgkin lymphoma.

Presented first were data from the Phase 3 CLL11 study, which was designed to compare the efficacy and safety of rituximab and obinutuzumab (a glycoengineered anti-CD20 monoclonal antibody), both in combination with the chemotherapy agent chlorambucil, in patients with chronic lymphocytic leukemia. In this final analysis of the study, obinutuzumab was found to significantly prolong progression-free survival, time to next treatment and overall survival compared with rituximab; however, caution must be exercised as obinutuzumab was associated with greater toxicity than rituximab.

Also presented in this session were data from the Phase 3 RELEVANCE study, which was designed to compare the efficacy and safety of rituximab combined with either chemotherapy (current standard of care) or the immunomodulatory agent lenalidomide, in patients with follicular lymphoma. The two treatments were found to have comparable efficacy, but differences in their safety profiles, suggesting that rituximab plus lenalidomide may be a treatment option for certain patients at risk of toxicities associated with the current standard of care.

In summary, a wealth of interesting and exciting research was presented across the 4-day congress in both oral and poster format. We can’t wait to see the latest data at next year’s congress in Amsterdam; we hope to see you there!

Share

TwitterFacebookLinkedInGoogle+Email

Spirit at eyeforpharma Barcelona, 13-15 March 2018

A team from Spirit Group attended eyeforpharma Medical Affairs in Barcelona to participate in lively discussions surrounding the evolution of Medical Affairs. One of the hot topics this year was Maintaining MSL authenticity under commercial pressures, with both plenary sessions and a Spirit-facilitated roundtable being dedicated exclusively to this subject. Key themes feeding into discussions on…Read more »

A team from Spirit Group attended eyeforpharma Medical Affairs in Barcelona to participate in lively discussions surrounding the evolution of Medical Affairs. One of the hot topics this year was Maintaining MSL authenticity under commercial pressures, with both plenary sessions and a Spirit-facilitated roundtable being dedicated exclusively to this subject.

Key themes feeding into discussions on maintaining MSL authenticity – during the plenary, the roundtable and a pre-congress survey of key Medical stakeholders – are captured in our eyeforpharma Barcelona Medical Affairs Newsletter.

Please click here to request a copy or to discuss any aspect of the evolution of the Medical function further.

 

Share

TwitterFacebookLinkedInGoogle+Email

Spirit at the European ISMPP meeting in London, 23-24 January 2018

Increased data transparency, drives for open access as standard, and progress towards greater patient involvement in publications were the key themes at the 2018 European ISMPP meeting. The Spirit team were represented onsite by Amanda Pedder, Medical Writer and Ben Caldwell, Scientific Director. Exciting news came courtesy of Shire, who have committed to submit all…Read more »

Increased data transparency, drives for open access as standard, and progress towards greater patient involvement in publications were the key themes at the 2018 European ISMPP meeting. The Spirit team were represented onsite by Amanda Pedder, Medical Writer and Ben Caldwell, Scientific Director. Exciting news came courtesy of Shire, who have committed to submit all Shire-supported research manuscripts to journals offering open access. Their press release on the topic is available here: https://www.shire.com/en/newsroom/2018/january/xajhds

Over 300 publication experts attended the meeting; pharma/biotech staff represented almost one-third of the audience, and medical communications agencies were the majority of the remainder. The meeting was extremely stimulating, with a great deal of exciting research and debate presented both in the plenary sessions and in poster form. We’re looking forward to the next meeting already!

Share

TwitterFacebookLinkedInGoogle+Email

Collaboration & Crystals!

We had a fantastic Company Meeting last week at the Great John Street Hotel in Manchester! Pioneers in Science connected to Manchester was the theme behind our teams (Lovell, Dalton, Rutherford, Kilburn) which set the scene for a day centred around innovative thinking to address common challenges in the Medical Communications environment. With several new…Read more »

We had a fantastic Company Meeting last week at the Great John Street Hotel in Manchester!

Pioneers in Science connected to Manchester was the theme behind our teams (Lovell, Dalton, Rutherford, Kilburn) which set the scene for a day centred around innovative thinking to address common challenges in the Medical Communications environment.

With several new starters in our midst as we continue to grow, we also capitalised on a prime opportunity to share insight and opinion to help shape the future of Spirit.

Not satisfied with just the fantastic outputs of this extremely productive meeting, we then faced the ultimate challenge… testing our skill, physical and mental abilities in the Crystal Maze – ‘Start the fans please!’

Well done to Team Dalton who came top of the leader board!, although all teams partook in a well-deserved celebratory drinkie…or three 😊

 

Share

TwitterFacebookLinkedInGoogle+Email

Never a dull moment during congress season!

Our Client Services and Medical & Scientific Services teams are extremely busy co-ordinating a myriad of activities around three major congresses this month. Through fantastic teamwork, we have successfully navigated … – The challenge of obtaining over the summer holidays all author approvals required to ensure finalisation of oral presentations, print sign off and shipping…Read more »

Our Client Services and Medical & Scientific Services teams are extremely busy co-ordinating a myriad of activities around three major congresses this month. Through fantastic teamwork, we have successfully navigated …

– The challenge of obtaining over the summer holidays all author approvals required to ensure finalisation of oral presentations, print sign off and shipping of multiple postersincluding a winner of the Best Poster Award at ESMO!

– Working closely with authors and journal publishers to achieve hot-off-the-press data release in parallel with the relevant congress

– Co-ordination of a series of webinars delivering up-to-date data and clinical developments, broadcast simultaneously in multiple languages, with live question and answer functionality

– Juggling of multiple components to deliver cutting-edge, innovatively-themed symposia employing novel formats and the latest technologies

– Delivery of highly interactive content and high-spec animations for exhibition booths

– And, of course… smooth handling of all unforeseen circumstance, such as the need for last-minute filming of keynote speakers who can’t make it to the congress at the final hour.

In between all this, we are still finding time to fit in holidays of our own, and participate in bake offs and crowd surfing!

 

 

 

 

 

Share

TwitterFacebookLinkedInGoogle+Email

Helping you navigate a predatory environment

Predatory publishing remains a ‘hot topic’, as highlighted by Discover magazine’s recent ‘Star Wars sting’. Authors are under increasing pressure to ensure their work is submitted to a credible journal. At Spirit, our team of experienced scientific leads is well versed in overcoming publishing challenges, so much so that a long-standing client recently invited us…Read more »

Predatory publishing remains a ‘hot topic’, as highlighted by Discover magazine’s recent ‘Star Wars sting’. Authors are under increasing pressure to ensure their work is submitted to a credible journal.

At Spirit, our team of experienced scientific leads is well versed in overcoming publishing challenges, so much so that a long-standing client recently invited us to present at a meeting for physicians involved in the treatment of opioid disorders.

Tony (Senior Scientific Director) and Asif (Managing Director) hosted an interactive workshop on Writing addiction case reports for peer-reviewed publications. Case study development best practice, common barriers to publication, and how these can be overcome in a predatory environment were core themes addressed throughout this very well received session.

For more information on case report best practice, or to explore other ways we can forge mutually beneficial partnerships, please feel free to visit our new look website www.spirit.global.

 

Share

TwitterFacebookLinkedInGoogle+Email

We’re hiring – Account Director

Spirit is an independent, agile global medical communications agency with a passion for service excellence, thanks to the talented individuals in our team. We’re growing and seek a self-starter with a proven track record to join as an Account Director/Leader, to partner with clients who have global responsibilities for pipeline and marketed products in a variety of…Read more »

Spirit is an independent, agile global medical communications agency with a passion for service excellence, thanks to the talented individuals in our team. We’re growing and seek a self-starter with a proven track record to join as an Account Director/Leader, to partner with clients who have global responsibilities for pipeline and marketed products in a variety of therapy areas.
This role is hands-on, and requires both strategic and tactical know-how, combined with strong leadership and communication skills to ensure our client relationships continue to flourish.

If you’re passionate about building great relationships with clients and external stakeholders, and bringing new ideas to shape our business….. we want to hear from you.

Above all we seek talented team-players, who demonstrate entrepreneurial spirit and a continuous desire to enable clients to succeed.
We offer a flexible, relaxed and fun environment where new ideas and continuous improvement are embraced.

Interested?…… please contact Asif Zaman for an exploratory discussion:-

asif.zaman@spirit.global

Share

TwitterFacebookLinkedInGoogle+Email